Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14732 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Yichao Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Rats, Sprague-Dawley, Disease Models, Animal, Receptors, Neuropeptide Y. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Provincial Natural Science Foundation of Hunan, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Aims
Cardiac dysfunction is commonly observed in patients with subarachnoid haemorrhage (SAH). However, the specific timeline of cardiac remodelling and the underlying mechanisms responsible for this effect following SAH remain unknown. This study aims to explore the impact of SAH on cardiac dysfunction and its potential mechanisms over time. Methods and results In Protocol 1, we investigated cardiac function and potential mechanisms in a Sprague-Dawley rat model of SAH at six time points (baseline and Days 1, 3, 7, 14, and 28) while exploring the underlying mechanisms. Our assessments included the haemodynamic profile, echocardiography, and the concentrations of plasma biomarkers at various time points post-SAH. We determined neuropeptide Y (NPY) 1–5 receptor protein expression levels through western blotting. In Protocol 2, we administered an NPY1 receptor antagonist to evaluate the effects of cardiac dysfunction induced by SAH on Day 3. In Protocol 1, SAH gradually provoked cardiac systolic dysfunction during the acute phase, reaching its peak on Day 3 without concurrent alterations in wall thickness. However, no significant changes were observed from Days 14 to 28 compared with Day 0. The changes in cardiac dysfunction were consistent with myocardial injury, inflammatory biomarkers, and NPY levels. SAH resulted in a heightened heart rate and systolic blood pressure, correlating with elevated epinephrine and norepinephrine levels. In Protocol 2, the administration of the NPY1 receptor antagonist effectively ameliorated cardiac dysfunction.
Conclusions
SAH induces transient cardiac dysfunction in the acute phase, and the underlying mechanisms for this response involve the NPY–NPY1 receptor pathway, otherwise known as catecholamines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Mingxian Chen
Förderung
- National Natural Science Foundation of China
- Provincial Natural Science Foundation of Hunan
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xiao, Y., Lai, X., Wang, Z., Wang, S., Wu, Z., Liu, Q., Chen, M., & Zhou, S. (2024). Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms. ESC Heart Failure. https://doi.org/10.1002/ehf2.14732
Vancouver
Xiao Y, Lai X, Wang Z, Wang S, Wu Z, Liu Q, et al. Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms. ESC Heart Failure. 2024. doi:10.1002/ehf2.14732
BibTeX
@article{Xiao2024,
author = {Xiao, Yichao and Lai, Xin and Wang, Zhuo and Wang, Songyun and Wu, Zhihong and Liu, Qiming and Chen, Mingxian and Zhou, Shenghua},
title = {Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14732}
}
EUVIMED